Article Versions Notes

Aguiar TKB, Mesquita FP, Neto NAS, Gomes FÍR, Freitas CDT, Carneiro RF, Nagano CS, Alencar LMR, Santos-Oliveira R, Oliveira JTA, et al. No Chance to Survive: Mo-CBP₃-PepII Synthetic Peptide Acts on Cryptococcus neoformans by Multiple Mechanisms of Action. Antibiotics. 2023; 12(2):378. https://doi.org/10.3390/antibiotics12020378

Aguiar, Tawanny K. B., Felipe P. Mesquita, Nilton A. S. Neto, Francisco Í. R. Gomes, Cleverson D. T. Freitas, Rômulo F. Carneiro, Celso S. Nagano, Luciana M. R. Alencar, Ralph Santos-Oliveira, Jose T. A. Oliveira, and et al. 2023. "No Chance to Survive: Mo-CBP₃-PepII Synthetic Peptide Acts on Cryptococcus neoformans by Multiple Mechanisms of Action" Antibiotics 12, no. 2: 378. https://doi.org/10.3390/antibiotics12020378

Aguiar, T. K. B., Mesquita, F. P., Neto, N. A. S., Gomes, F. Í. R., Freitas, C. D. T., Carneiro, R. F., Nagano, C. S., Alencar, L. M. R., Santos-Oliveira, R., Oliveira, J. T. A., & Souza, P. F. N. (2023). No Chance to Survive: Mo-CBP₃-PepII Synthetic Peptide Acts on Cryptococcus neoformans by Multiple Mechanisms of Action. Antibiotics, 12(2), 378. https://doi.org/10.3390/antibiotics12020378